Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. (2020)

First Author: Wilkinson S

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dom.13970

PubMed Identifier: 31957254

Publication URI: http://europepmc.org/abstract/MED/31957254

Type: Journal Article/Review

Volume: 22

Parent Publication: Diabetes, obesity & metabolism

Issue: 5

ISSN: 1462-8902